NEW YORK, Oct. 6 (GenomeWeb News) - Norak Biosciences has licensed its Transfluor technology to drug maker Merck for use in its G protein-coupled receptor drug discovery efforts.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.